Editorial
doi: 10.1016/j.jhep.2010.12.016.
Epub 2011 Jan 11.
New protease inhibitors for HCV--help is on the way
- PMID: 21232563
- DOI: 10.1016/j.jhep.2010.12.016
Item in Clipboard
Editorial
New protease inhibitors for HCV--help is on the way
J Hepatol.
2011 Jun.
Free article
Erratum in
- J Hepatol. 2011 Oct;55(4):952
No abstract available
Comment on
-
Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection.J Hepatol. 2011 Jun;54(6):1114-22. doi: 10.1016/j.jhep.2010.08.040. Epub 2010 Nov 11. J Hepatol. 2011. PMID: 21145839 Clinical Trial.
-
Treatment of chronic hepatitis C patients with the NS3/4A protease inhibitor danoprevir (ITMN-191/RG7227) leads to robust reductions in viral RNA: a phase 1b multiple ascending dose study.J Hepatol. 2011 Jun;54(6):1130-6. doi: 10.1016/j.jhep.2010.11.001. Epub 2011 Feb 24. J Hepatol. 2011. PMID: 21145848 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
